Korean J Med.  2015 Feb;88(2):135-141. 10.3904/kjm.2015.88.2.135.

Optimal Management of Heart Failure with Preserve Ejection Fraction

Affiliations
  • 1Department of Cardiovascular, The Catholic University of Korea Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. whitesh@catholic.ac.kr

Abstract

More than 50% of patients who are diagnosed with heart failure have preserved ejection fraction (HFpEF), and they have an equally poor prognosis when compared to patients with heart failure with reduced ejection fraction (HFrEF). However, a comprehensive understanding and awareness of heart failure with preserved ejection fraction is still limited and there are currently no optimized treatments to improve morbidity and mortality in these patients. This review summarizes the differences in the epidemiology, pathophysiology, diagnosis, and prognosis between HFpEF and HFrEF. We also review current management strategies of HFpEF patients according to evidence-based treatment guidelines.

Keyword

Heart Failure, Diastolic; Treatment

MeSH Terms

Diagnosis
Epidemiology
Heart Failure*
Heart Failure, Diastolic
Humans
Mortality
Prognosis
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr